Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins

C. Pantarotto, M. Arboix, P. Sezzano, R. Abbruzzi

    Research output: Contribution to journalArticleResearchpeer-review

    47 Citations (Scopus)

    Abstract

    5,5-Diphenylhydantoin irreversibly binds to rat liver microsomes and the process requires NADPH and O2. Protein binding was significantly enhanced when experiments were carried out with liver microsomal preparations from β-naphthoflavone and 3-methylcholanthrene pretreated animals whereas pretreatment with phenobarbital significantly reduced it. Carbon monoxide, β-diethylaminoethyl-diphenylpropylacetate and glutathione inhibited drug covalent binding to microsomal proteins. In contrast, enhanced drug binding was observed when trichloropropene oxide and cyclohexene oxide, two epoxide hydrolase inhibitors, were added to the incubation mixture. 5,5-Diphenylhydantoin in vitro metabolism was quantitatively determined by gas liquid chromatography with selected ion monitoring. A good correlation seems to exist between drug covalent binding and the microsomal process of 5,5-diphenylhydantoin hydroxylation to 5-(4-hydroxyphenyl)-5-phenylhydantoin. The results presented support a previous hypothesis on the intermediacy of arene oxides in the biotransformation of this drug. © 1982.
    Original languageEnglish
    Pages (from-to)1501-1507
    JournalBiochemical Pharmacology
    Volume31
    Issue number8
    DOIs
    Publication statusPublished - 15 Apr 1982

    Fingerprint

    Dive into the research topics of 'Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins'. Together they form a unique fingerprint.

    Cite this